Skip to main content
Clinical Trials/NCT05317039
NCT05317039
Unknown
Not Applicable

Evaluation of Piezosurgical Buccal Plate Repositioning Technique for Horizontal Alveolar Ridge Augmentation Comparing Between Two Different Grafting Materials (a Randomized Clinical Trial)

Hams Hamed Abdelrahman1 site in 1 country18 target enrollmentAugust 15, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Alveolar Bone Loss
Sponsor
Hams Hamed Abdelrahman
Enrollment
18
Locations
1
Primary Endpoint
change in alveolar ridge width
Last Updated
4 years ago

Overview

Brief Summary

Achieving prosthetically driven implant placement is a highly predictable treatment modality with reliable long-term results. Different surgical procedures have been used as a solution for reconstructing of the alveolar ridge with deficient volume. In the present study we demonstrate a modified alveolar ridge split technique for horizontal alveolar ridge augmentation (buccal plate repositioning technique) using the piezotome surgery. Evaluation of the effect of silica-calcium phosphate nanocomposite (SCPC) graft material versus demineralized freeze dried bone allograft (DFBA) in horizontal alveolar ridge augmentation before implant insertion will be performed.

Registry
clinicaltrials.gov
Start Date
August 15, 2021
End Date
June 30, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Hams Hamed Abdelrahman
Responsible Party
Sponsor Investigator
Principal Investigator

Hams Hamed Abdelrahman

Assistant lecturer of DPH and Clinical statistician

Alexandria University

Eligibility Criteria

Inclusion Criteria

  • Patients with horizontal atrophy of the posterior mandible with pristine residual alveolar crest width from 2 to 4 mm.
  • Augmented area length in the mesial-distal direction of less than 20 mm.
  • Adequate physically healthy condition.

Exclusion Criteria

  • A systemic disease that would contraindicate oral surgical treatment.
  • Treated patients who had undergone therapy involving radiation
  • Patients who had received bone resection as part of an oncological treatment after a bone augmentation procedure.
  • Patients are subjected to intravenous and/or oral bisphosphonate therapy after the bone augmentation procedure.

Outcomes

Primary Outcomes

change in alveolar ridge width

Time Frame: at baseline and 6 months

All patients will receive a CBCT scan; immediately after surgery and at 6 months post-operatively. The images will be analyzed using OnDemand3D software (Cybermed Inc) CBCT analyzing software and compared to the pre-operative scan for alveolar ridge width evaluation.

Study Sites (1)

Loading locations...

Similar Trials